PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Acquires Encapsulation Technology and Expands Ruminant Portfolio - Kemin Industries, Inc. announced today that it has acquired a majority share of an Italian manufacturer of encapsulation technology and products sold via distribution by Soda Feed Ingredients
Kemin Acquires Encapsulation Technology and Expands Ruminant Portfolio

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2010/01/06 - Kemin Industries, Inc. announced today that it has acquired a majority share of an Italian manufacturer of encapsulation technology and products sold via distribution by Soda Feed Ingredients.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This acquisition expands Kemin’s already robust product portfolio of animal feed ingredients to include unique encapsulation technologies and new ingredients for the dairy industry.

“Nutritionists are constantly challenged to maximize the digestibility of sometimes poorly absorbed feed ingredients,” says John Springate, Ph.D., president of Kemin Agrifoods. “Sound encapsulation, or the ability to time the release of active ingredients, can target absorption of ingredients at specific locations in the digestive tract. This unique delivery system provides optimum absorption of ingredients for maximum nutrition and health benefits.”

“We look forward to joining the Kemin team as we merge our strengths together to better serve both Kemin and Soda customers,” says Giancarlo Alloa Casale, president of Soda Feed Ingredients. “Our unique encapsulation technologies will provide additional value to Kemin’s product portfolio, leading to new and greater nutritional and health solutions. Kemin’s global sales and marketing network will undoubtedly lead to greater distribution of our technology in the animal feed ingredient market.”

Kemin will invest resources in research and development to apply these technologies in the food, pet food, nutraceutical and pharmaceutical industries. Through the delivery of active ingredients with slow release technologies, Kemin will maximize the use of encapsulation with all product applications where there is a benefit to customers.

New Technology and Products
New encapsulation technologies include: spray freezing, fluid bed, pan coating and coacervation. These unique encapsulation technologies provide a targeted release in the gastrointestinal tract, application for rumen bypass and protection for hard to handle active ingredients.

Additional products acquired expand Kemin’s ruminant portfolio as well as enhance its acidifier portfolio. These products, available in select regions, include: LYS-50™, Col 24™, METHIOPLUS™, Butyprol™, RepaXol™, FormaXol™ and Finicid™.

LYS-50™ is a cost effective source of rumen bypass and intestinally released lysine for use in dairy cattle.

Col 24™ is a cost effective source of rumen bypass and intestinally released choline chloride for use in dairy cattle.

METHIOPLUS™ is a cost effective source of rumen bypass and intestinally released methionine for use in dairy cattle. METHIOPLUS is available in North America, Central America and parts of South America and Asia.

Butyprol™ is an encapsulated source of butyric acid with a low butyrate smell.

RepaXol™ is a unique blend of highly concentrated, encapsulated essential oils.

FormaXol™ is a coated source of formic acid with citric acid and encapsulated essential oils into one powerful microgranule.

Finicid™ is a source of acids and nutritional ingredients that assists with increasing enzyme activity during late stages of finishing pigs.

Kemin® – Inspired Molecular Solutions™
Founded in 1961, the Kemin group of companies (kemin.com) provide health and nutritional solutions to the agrifood, food ingredients, pet food, human health and pharmaceutical industries. Kemin operates in more than 60 countries with manufacturing facilities in Belgium, Brazil, China, India, Singapore, South Africa, Thailand and the United States.

The AgriFoods businesses of Kemin focus on Total Nutrition™ to help customers achieve a highly effective, consistent system of profitable animal production. The essential combination of Kemin products with good nutrition and solid animal husbandry ensures that customers around the globe maintain profitability while enhancing the health and well being of animals.

For media inquiries, please contact:
Stephanie Wilson, 515-559-5482, stephanie.wilson[.]kemin.com.

[Content made possible by PRZOOM indexing services]

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Acquires Encapsulation Technology and Expands Ruminant Portfolio

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Erin Hockman 
515-559-5349 erin.hockman[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  SKS Media | SKS Associates Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)